Arkin Moshe
SEC-identified person · CIK 1321178 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Odysight.ai Inc. ODYS | Director | filed 2025 - 2026 |
| Sol-Gel Technologies Ltd. SLGL | Director · Chairman of Board and CEO | filed 2026 - 2026 |
| Werewolf Therapeutics, Inc. HOWL | Officer | filed 2021 - 2021 |
| Keros Therapeutics, Inc. KROS | Officer | filed 2020 - 2020 |
| Perrigo CO PRGO | Director · Vice Chairman | filed 2006 - 2011 |
| Neurogesx Inc NGSX | Officer | filed 2010 - 2011 |
| Orexigen Therapeutics, Inc. OREXQ | Officer | filed 2010 - 2010 |
| Ophthalmic Imaging Systems OISI | Director | filed 2009 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.